Vertical Research Downgrades Paramount Global to Mixed
Vertical Research downgrades Paramount Global (NASDAQ:PARA) from Positive to Mixed.
Needham Initiates Coverage On Definitive Healthcare with Buy Rating, Announces Price Target of $30
Needham analyst Ryan MacDonald initiates coverage on Definitive Healthcare (NASDAQ:DH) with a Buy rating and announces Price Target of $30.
Oppenheimer Initiates Coverage On Portman Ridge Finance with Perform Rating, Announces Price Target of $26
Oppenheimer analyst Mitchel Penn initiates coverage on Portman Ridge Finance (NASDAQ:PTMN) with a Perform rating and announces Price Target of $26.
Wolfe Research Initiates Coverage On Teleflex with Outperform Rating
Wolfe Research analyst Mike Polark initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating.
Wolfe Research Initiates Coverage On Medtronic with Underperform Rating
Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.
RBC Capital Downgrades Pioneer Natural Resources to Sector Perform
RBC Capital analyst Scott Hanold downgrades Pioneer Natural Resources (NYSE:PXD) from Outperform to Sector Perform.
RBC Capital Downgrades EOG Resources to Sector Perform
RBC Capital analyst Scott Hanold downgrades EOG Resources (NYSE:EOG) from Outperform to Sector Perform.
JP Morgan Initiates Coverage On Avid Technology with Overweight Rating, Announces Price Target of $33
JP Morgan analyst Paul Chung initiates coverage on Avid Technology (NASDAQ:AVID) with a Overweight rating and announces Price Target of $33.
SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64
SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.
Raymond James Maintains Outperform on CME Group, Lowers Price Target to $235
Raymond James analyst Patrick O'Shaughnessy maintains CME Group (NASDAQ:CME) with a Outperform and lowers the price target from $254 to $235.